Plexision
About
What does Plexision do?
Plexision is a developer of cellular biomarker tests for personalized diagnostics. Their core products include tests for transplant rejection, viral infections like CMV and EBV, COVID-19 immunity, immune deficiency, and immuno-oncology. They serve patients and healthcare providers by offering insights into cell-mediated immunity and immune responses.
What is Plexision's valuation?
StartupHub estimates Plexision's effective valuation at $6.6M (range $4.7M to $11.2M, 16% confidence), based on comparable companies in the sector.
How much funding has Plexision raised?
Plexision has raised a total of $2M in funding. The most recent round on record is Seed.
Where is Plexision headquartered?
Plexision is headquartered in San Francisco, United States.
When was Plexision founded?
Plexision was founded in 2019.
What industry does Plexision operate in?
Plexision operates in Agentic AI, AI Agent, Workflow Automation, Customer Service Automation, Conversational AI, API Platform.
How many employees does Plexision have?
Plexision has approximately 11 people on record.
No comments yet. Be the first to share your take.